Web Analytics

3 Latest Announced Rounds

$1,325.73M Raised in 74 Funding Rounds in the past 7 Days - View All

Funding Round Profile

MDisrupt

start up
United States - Austin, TX
  • 10/10/2023
  • Seed
  • $3,000,000

MDisrupt is an enablement platform for digital health designed to connect health experts with digital health companies so the most impactful health products can make it to market quickly and responsibly.

Our On Demand Experts Include:
- Physicians
- Chief Medical Officers
- Regulatory Experts
- Lab Directors and Operations
- Health Product Leaders
- Health Economists
- Market Access and Reimbursement experts
- Commercialization and channel specialists
- Health system leaders
- Clinical trial designers
- Behavioral scientists
- Data scientists


Related People

Ruby Gadelrab TudorFounder

Ruby Gadelrab Tudor United States - Austin, Texas Metropolitan Area

With over 20 years of experience in the genomics and healthtech space, Ruby Gadelrab is a healthcare innovator and leader who is passionate about accelerating the adoption of health technologies that can improve population health and precision medicine. She is the CEO and Founder of MDisrupt, the world's first platform for connecting clinicians and scientists with digital health innovators, to help them build, commercialize, and scale their health products, quickly and responsibly.

Ruby has a strong background in developing and executing go-to-market strategies, channel and partnership development, customer acquisition, branding, storytelling, and global campaigns for both B2B and B2C segments. She has worked with some of the leading companies in the genomics and healthtech space, such as 23andMe, Genome Medical, Color Genomics, Drawbridge Health, and Genomics PLC, as a consultant, advisor, or mentor. She also has extensive experience in international markets, especially in China, Latin America, EMEA, and APAC. As a mentor and strategic advisor, Ruby empowers digital health entrepreneurs with the clinical and scientific expertise they need to succeed.